यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

teva pharma b.v. - docetaxel - carcinoma, non-small-cell lung; breast neoplasms; prostatic neoplasms - antineoplastic agents - breast cancerdocetaxel teva pharma monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.non-small-cell lung cancerdocetaxel teva pharma is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer after failure of prior chemotherapy.docetaxel teva pharma in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small-cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancerdocetaxel teva pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

pensa pharma ab - paracetamol - tablets - 500 milligram

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

pensa pharma ab - paracetamol - tablets - 1000 milligram

इसराइल - अंग्रेज़ी - Ministry of Health

mbi pharma ltd., israel - dexamethasone as sodium phosphate - solution for injection - dexamethasone as sodium phosphate 4 mg/ml - dexamethasone - dexamethasone kern pharma is indicated in the treatment of:• endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.• allergy: severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.• ophtalmic: serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.• inflammatory bowel dis.: systemic treatment in exacerbations of ulcerative colitis and regional enteritis.• dermatological diseases (pemphigus, stevens johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • respiratory diseases (symptomatic sarcoidosis, berylliosis, loeffler's syndrome)• haematologica

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - donepezil hydrochloride - film-coated tablet - 10 milligram(s) - anticholinesterases; donepezil

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - donepezil hydrochloride - film-coated tablet - 5 milligram(s) - anticholinesterases; donepezil

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - metformin hydrochloride - film-coated tablet - 850 milligram(s) - biguanides; metformin

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - metformin hydrochloride - film-coated tablet - 1000 milligram(s) - biguanides; metformin

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - metformin hydrochloride - film-coated tablet - 500 milligram(s) - biguanides; metformin

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - omeprazole - gastro-resistant capsule, hard - 10 milligram(s) - proton pump inhibitors; omeprazole